Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human vaginal metagenome

ABSTRACT: The Vaginal Microbiome: Disease, Genetics and the Environment

PROVIDER: PRJNA46877 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
		Other
	SRR15600835_1.fastq.gz	Fastqsanger.gz
	SRR15600835_2.fastq.gz	Fastqsanger.gz
	SRR15600836_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 2263

Similar Datasets

human metagenome

Project description:The Vaginal Microbiome: Disease, Genetics and the Environment

| PRJNA46311 | ENA

Human Vaginal Microbiome

Project description:The Vaginal Microbiome: Disease, Genetics and the Environment - Demonstration project for Human Microbiome Project (HMP)

| PRJNA51443 | ENA

The Vaginal Microbiome: Disease, Genetics and the Environment

Project description:The Vaginal Microbiome: Disease, Genetics and the Environment

| PRJNA74947 | ENA

human vaginal metagenome

Project description:Vaginal microbiome

| PRJNA1057978 | ENA

The Dynamics of the Vaginal Microbiome During Infertility Therapy with In Vitro Fertilization-Embryo Transfer

Project description:Clinical treatment protocols for infertility with in vitro fertilization-embryo transfer (IVF-ET) provide a unique opportunity to assess the human vaginal microbiome in defined hormonal milieu. Herein, we have investigated the association of circulating ovarian-derived estradiol (E2) and progesterone (P4) concentrations to the vaginal microbiome. Thirty IVF-ET patients were enrolled in this study, after informed consent. Blood was drawn at four time points during the IVF-ET procedure. In addition, if a pregnancy resulted, blood was drawn at 4-to-6 weeks of gestation. The serum concentrations of E2 and P4 were measured. Vaginal swabs were obtained in different hormonal milieu. Two independent genome-based technologies (and the second assayed in two different ways) were employed to identify the vaginal microbes. The vaginal microbiome underwent a transition with a decrease in E2 (and/or a decrease in P4). Novel bacteria were found in the vagina of 33% of the women undergoing IVF-ET. Our approach has enabled the discovery of novel, previously unidentified bacterial species in the human vagina in different hormonal milieu. While the relationship of hormone concentration and vaginal microbes was found to be complex, the data support a shift in the microbiome of the human vagina during IVF-ET therapy using standard protocols. The data also set the foundation for further studies examining correlations between IVF-ET outcome and the vaginal microbiome within a larger study population.

2011-10-24 | E-MEXP-2958 | biostudies-arrayexpress

human vaginal metagenome

Project description:Human associated vaginal microbiome Metagenome

| PRJNA549661 | ENA

human vaginal metagenome

Project description:Smoking and the Vaginal Microbiome

| PRJNA391039 | ENA

human vaginal metagenome

Project description:Vaginal microbiome of Canadian women

| PRJNA278895 | ENA

Human vaginal metagenome

Project description:Vaginal microbiome of South African women